Case Report: Therapeutic Response to Chemo-Immunotherapy in an Advanced Large Cell Lung Carcinoma Patient With Low Values of Multiple Predictive Biomarkers

Immune checkpoint inhibitors have revolutionized the treatments of lung cancers, and multiple predictive biomarkers alone or in combination help clinicians with the appropriate therapeutic selections. Recently, chemo-immunotherapy has been recommended for treating advanced non-small cell lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guihua, Chai, Qin, Xiao, Yajie, Peng, Wenying, Teng, Miao, Wang, Jingyi, Lin, Hanqing, Su, Xiaofan, Wu, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876253/
https://www.ncbi.nlm.nih.gov/pubmed/33584678
http://dx.doi.org/10.3389/fimmu.2020.607416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876253/
https://www.ncbi.nlm.nih.gov/pubmed/33584678
http://dx.doi.org/10.3389/fimmu.2020.607416

Ejemplares similares